ADYTON s.r.o. Information

ADYTON is a clinical commercialization partner helping global MedTech, Pharma, and AI-enabled SaaS innovators bring complex healthcare technologies into real clinical practice across Central Europe. We focus on turning advanced medical devices, materials, pharmaceutical innovations, and digital health solutions into sustainable everyday clinical use — not as a transactional distributor, but as a long-term partner responsible for execution, adoption, and outcomes. Operating across Poland, the Czech Republic, and Slovakia, ADYTON supports a 54-million-patient healthcare market within the EU regulatory framework, working with more than 200 public hospitals and 50 private clinics. Our strength lies in integrating the full execution stack required for complex healthcare innovation, including: • MDR-compliant regulatory and market access • reimbursement strategy and pricing pathways • clinical education, OR presence, and application support • logistics, servicing, and lifecycle management • long-term collaboration with Key Opinion Leaders ADYTON partners with both established global manufacturers and carefully selected technology innovators, particularly in areas where clinical complexity, regulation, and trust are critical. Our portfolio spans interventional cardiology, spine and neurosurgery, orthopaedics, interventional radiology, advanced biomaterials, infection prevention, AI-enabled clinical software, SaaS platforms, and selected pharmaceutical innovations. We build focused clinical ecosystems — combining hardware, software, and expertise — to help physicians deliver better outcomes while reducing friction for hospitals operating in highly regulated healthcare systems. ADYTON remains hands-on, independent, and deeply rooted in clinical reality. Our ambition is simple: to be the trusted partner for healthcare innovation entering and scaling within European clinical systems.